Abstract
BackgroundTo summarize our clinical experience and review our technique of retroperitoneal robotic-assisted laparoscopic partial nephrectomy (RALPN) in management of T1b renal carcinoma. Assess the clinical efficacy and safety of retroperitoneal RALPN.MethodsRetrospective review of 52 T1b renal carcinoma patients underwent retroperitoneal RALPN form January 2014 to October 2016. The patients included 30 males and 22 females, with an average age of (55.2±9.5) years old. There were 32 tumors in the left and 20 in the right. The mean lesion diameter was 4.5±0.7 cm.ResultsAll cases were performed successfully. The operation was completed in a mean of 80.5±12.3 min, the mean warm ischemia time was 17.4±5.1 min, the mean blood loss was 38.2±7.4 mL and the mean extubation time was 2.1±0.7 d. Postoperative pathology reported malignant tumor in all cases, including renal clear cell carcinoma in 45 cases, papillary renal cell carcinoma in 5 cases and chromophobe cell carcinoma in 2 cases. The surgical margin of all cases were negative.ConclusionsRetroperitoneal RALPN is an effective, safe and minimally invasive surgical management for T1b renal carcinoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
